CD55-DEFICIENT PROTEIN-LOSING ENTEROPATHY
Clinical trials for CD55-DEFICIENT PROTEIN-LOSING ENTEROPATHY explained in plain language.
Never miss a new study
Get alerted when new CD55-DEFICIENT PROTEIN-LOSING ENTEROPATHY trials appear
Sign up with your email to follow new studies for CD55-DEFICIENT PROTEIN-LOSING ENTEROPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Life-Saving drug offered to children with rare immune disease
Disease control APPROVED_FOR_MARKETINGThis program provides access to an experimental drug called pozelimab for patients with CHAPLE disease, a rare and potentially life-threatening immune disorder that usually appears in childhood. The main goal is to document the long-term safety of the treatment in these patients.…
Matched conditions: CD55-DEFICIENT PROTEIN-LOSING ENTEROPATHY
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Special access granted for rare gut disease treatment
Disease control APPROVED_FOR_MARKETINGThis program provides special access to an investigational drug called pozelimab for patients with a rare, severe digestive disorder known as CD55-deficient protein-losing enteropathy. It is not a standard clinical trial but a pathway for individual patients to request the drug w…
Matched conditions: CD55-DEFICIENT PROTEIN-LOSING ENTEROPATHY
Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC